Proteins > Gamma-secretase subunit APH-1B
Page last updated: 2024-08-07 17:20:07
Gamma-secretase subunit APH-1B
A gamma-secretase subunit APH-1B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WW43]
Synonyms
APH-1b;
Aph-1beta;
Presenilin-stabilization factor-like
Research
Bioassay Publications (29)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (20.69) | 29.6817 |
2010's | 20 (68.97) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Compounds (21)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
cholanic acid | Homo sapiens (human) | EC50 | 5.7000 | 1 | 1 |
t0901317 | Homo sapiens (human) | EC50 | 3.6000 | 1 | 1 |
ly 450139 | Homo sapiens (human) | EC50 | 0.1259 | 1 | 1 |
ly 411575 | Homo sapiens (human) | EC50 | 0.0001 | 1 | 1 |
begacestat | Homo sapiens (human) | EC50 | 0.0136 | 2 | 2 |
e 2012 | Homo sapiens (human) | EC50 | 0.0830 | 1 | 1 |
ro 4929097 | Homo sapiens (human) | EC50 | 0.0095 | 2 | 2 |
Drugs with Other Measurements
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 25, Issue:4, 2015
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 20, Issue:17, 2010
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Development of clickable active site-directed photoaffinity probes for γ-secretase.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 22, Issue:8, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Piperidine-derived gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.The Journal of biological chemistry, , Aug-24, Volume: 282, Issue:34, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 17, Issue:1, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Generation of Leads for γ-Secretase Modulation.Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.ACS medicinal chemistry letters, , Oct-12, Volume: 8, Issue:10, 2017
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?Journal of medicinal chemistry, , Aug-25, Volume: 59, Issue:16, 2016
Potent benzoazepinone γ-secretase modulators with improved bioavailability.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 25, Issue:17, 2015
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.Journal of medicinal chemistry, , Nov-08, Volume: 55, Issue:21, 2012
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 21, Issue:2, 2011
Iminoheterocycles as gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 20, Issue:18, 2010
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.Journal of medicinal chemistry, , Nov-25, Volume: 58, Issue:22, 2015
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 16, Issue:2, 2006
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.Bioorganic & medicinal chemistry letters, , May-01, Volume: 21, Issue:9, 2011
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor.Journal of medicinal chemistry, , Apr-12, Volume: 55, Issue:7, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Enables
This protein enables 3 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
protein-macromolecule adaptor activity | molecular function | The binding activity of a protein that brings together two or more macromolecules in contact, permitting those molecules to function in a coordinated way. The adaptor can bring together two proteins, or a protein and another macromolecule such as a lipid or a nucleic acid. [GOC:bf, GOC:mah, GOC:vw] |
endopeptidase activator activity | molecular function | Binds to and increases the activity of an endopeptidase. [GOC:dph, GOC:tb] |
Located In
This protein is located in 6 target(s):
Target | Category | Definition |
Golgi membrane | cellular component | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. [GOC:mah] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
endosome membrane | cellular component | The lipid bilayer surrounding an endosome. [GOC:mah] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
transport vesicle | cellular component | Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell. [GOC:mah, PMID:22160157] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
gamma-secretase complex | cellular component | A protein complex that has aspartic-type endopeptidase activity and contains a presenilin catalytic subunit (either PSEN1 or PSEN2), an APH1 subunit (multiple genes and splice variants exist), nicastrin (NCT), and presenilin enhancer (aka PEN-2 or Psenen), as the core complex. Variants of the complex with different subunit compositions differ in localization and specific substrates. Additionally, variants of the complex exist that contain a additional regulatory subunit as well as the four core subunits; known regulatory subunits include gamma-secretase-activating protein (aka gSAP), TMP1 (aka TMED10), and CD147 antigen (aka basigin). Gamma-secretase cleaves type I transmembrane protein substrates, including the cell surface receptor Notch and the amyloid-beta precursor protein. [GOC:krc, PMID:15286082, PMID:15890777, PMID:17047368, PMID:22122073, PMID:25565961, PMID:28320827, PMID:32616437] |
Involved In
This protein is involved in 7 target(s):
Target | Category | Definition |
Notch receptor processing | biological process | The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor. [PMID:12651094, PMID:14986688] |
positive regulation of endopeptidase activity | biological process | Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. [GOC:dph, GOC:tb] |
protein processing | biological process | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. [GOC:curators, GOC:jl, GOC:jsg] |
membrane protein intracellular domain proteolysis | biological process | The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain. [PMID:12808018] |
amyloid-beta formation | biological process | The generation of amyloid-beta by cleavage of the amyloid precursor protein (APP). [GOC:mah] |
amyloid precursor protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
Notch signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to the receptor Notch on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:go_curators, GOC:signaling] |